Using a panel of colorectal cancer cells that express ARID1A vs. a panel of ARID1A-deficient cells, the authors showed that downregulation of ARID1B using siRNA increased the sensitivity to IR in cells lacking both subunits. Here, ARID1B is linked to colorectal cancer.